ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
WILLIAM WONG MD

Cardiovascular Disease

1,505

$47.2K

219
192 are 65+

N/A
N/A

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 28%

$31
Average prescription price

Avg: $67

AARON JORDAN MD

Cardiovascular Disease

16,694

$704K

633
541 are 65+

7%
patients receiving schedule two controlled substances

Avg: 0%

27%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 28%

$42
Average prescription price

Avg: $67

MOHINDER POONIA MD

Cardiovascular Disease

9,978

$564K

402
308 are 65+

N/A

23%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 28%

$57
Average prescription price

Avg: $67

WINDGROVE DANIEL M.D

Cardiovascular Disease

2,655

$94K

82
42 are 65+

22%
patients receiving schedule two controlled substances

Avg: 0%

52%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$35
Average prescription price

Avg: $67

HONG-LING LEE M.D.

Cardiovascular Disease

6,365

$397K

268
220 are 65+

N/A

22%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$62
Average prescription price

Avg: $67

PRAKASH PATEL MD

Cardiovascular Disease

6,361

$284K

367
311 are 65+

N/A

10%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 28%

$45
Average prescription price

Avg: $67

GUY CURTIS M.D.

Cardiovascular Disease

4,487

$231K

361
348 are 65+

N/A
N/A

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$51
Average prescription price

Avg: $67

T.S.S RAJAN M.D

Cardiovascular Disease

2,238

$74.8K

70
57 are 65+

N/A

17%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 28%

$33
Average prescription price

Avg: $67

JOSE ROCAMORA MD

Cardiovascular Disease

45,055

$2.14M

1473
1174 are 65+

1%
patients receiving schedule two controlled substances

Avg: 0%

21%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 28%

$48
Average prescription price

Avg: $67

GUSTIN HO M.D.

Cardiovascular Disease

21,804

$1.49M

1208
1174 are 65+

N/A

6%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$68
Average prescription price

Avg: $67

SIVA ARUNASALAM

Cardiovascular Disease

10,589

$1.22M

863
667 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

20%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 28%

$115
Average prescription price

Avg: $67

MICHAEL NORMAN DO

Cardiovascular Disease

21,812

$1.15M

1157
938 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

20%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 28%

$53
Average prescription price

Avg: $67

OSCAR ZAMBRANO M.D.

Cardiovascular Disease

22,733

$918K

1008
870 are 65+

N/A

12%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 28%

$40
Average prescription price

Avg: $67

RAJESH SURI MD

Cardiovascular Disease

11,440

$796K

419
342 are 65+

N/A

22%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 28%

$70
Average prescription price

Avg: $67

RAIF TAWAKOL MD

Cardiovascular Disease

6,643

$761K

113
61 are 65+

N/A

52%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 28%

$115
Average prescription price

Avg: $67

DALE STEMPLE M.D.

Cardiovascular Disease

10,989

$723K

410
270 are 65+

23%
patients receiving schedule two controlled substances

Avg: 0%

34%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$66
Average prescription price

Avg: $67

MIRKO GIACONI

Cardiovascular Disease

8,352

$656K

312
260 are 65+

N/A

12%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 28%

$78
Average prescription price

Avg: $67

ALYN ANDERSON M.D.

Cardiovascular Disease

7,682

$591K

446
397 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 28%

$77
Average prescription price

Avg: $67

WILLIAM CHUNG M.D.

Cardiovascular Disease

9,543

$580K

636
620 are 65+

N/A

9%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 28%

$61
Average prescription price

Avg: $67

MOHINDER SOHAL M.D.

Cardiovascular Disease

9,892

$413K

334
297 are 65+

N/A

8%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 28%

$42
Average prescription price

Avg: $67

JOEL JUAREZ-URIBE M.D.

Cardiovascular Disease

12,214

$402K

383
354 are 65+

N/A

11%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 28%

$33
Average prescription price

Avg: $67

FAYAZ ASGHAR MD

Cardiovascular Disease

4,057

$330K

217
194 are 65+

N/A

9%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 28%

$81
Average prescription price

Avg: $67

FARSHAD NOSRATIAN MD

Cardiovascular Disease

6,759

$302K

392
309 are 65+

N/A

16%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$45
Average prescription price

Avg: $67

MIN SHIN MD,APC

Cardiovascular Disease

7,383

$271K

258
220 are 65+

N/A

24%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 28%

$37
Average prescription price

Avg: $67

MELDON LEVY M.D.

Cardiovascular Disease

2,169

$192K

87
81 are 65+

N/A
N/A

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 28%

$89
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank